The Ministry of Health (Kemenkes) recorded three districts/cities in East Java with weekly average vaccinations exceeding the provincial average of 5,326.33 doses as of Friday, April 1, 2022.
The three top districts/cities with average vaccination figures above 7,000 doses are Jember, Kediri, and Tulungagung, with 14,138 doses, 7,616 doses, and 6,637 doses respectively.
Jember recorded the highest weekly average vaccination in East Java with 14,138 doses. Vaccine usage up to yesterday was recorded at 2.19 million doses. In the national dashboard recapitulation, the complete vaccination achievement in this region has reached 61.37 percent.
According to the Ministry of Health, the available vaccine stock in this district will run out in the next 20 days. This remaining usage period is calculated from the remaining stock of 291,220 doses and the highest weekly vaccine usage in East Java.
Kediri follows in second place. The complete vaccination achievement in this district has reached 72.49 percent. Compared to the previous week, the weekly average vaccination in this district reached 7,616 doses. The currently available vaccine stock is 146,970 doses. This stock is estimated to run out in the next 19 days.
Tulungagung follows, with a weekly average vaccination of 6,637 doses. Complete vaccination coverage has reached 74.19 percent. Malang, with 5,125 doses and a complete vaccination achievement of 76.62%, and Blitar, with 4,653 doses and a complete vaccination achievement of 71.95%, also reported.
Areas outside Java with the highest average vaccination rates include Simalungun, Rokan Hulu, and Lampung Tengah, with average vaccinations of 7,506 doses, 6,305 doses, and 6,083 doses respectively.
Although COVID-19 transmission has decreased in some areas, the government urges everyone to participate in reducing COVID-19 transmission by always wearing masks, maintaining distance, and frequently washing hands with soap and running water. Avoiding crowds and reducing mobility also contribute to suppressing the spread of the coronavirus.